Cite
HARVARD Citation
Intlekofer, A. et al. (2013). At the Bench: Preclinical rationale for CTLA‐4 and PD‐1 blockade as cancer immunotherapy. Journal of leukocyte biology. 94 (1), pp. 25-39. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Intlekofer, A. et al. (2013). At the Bench: Preclinical rationale for CTLA‐4 and PD‐1 blockade as cancer immunotherapy. Journal of leukocyte biology. 94 (1), pp. 25-39. [Online].